All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32331438

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32331438	A62V	RT	gag-pol	HIV Infections	D G R S C L	View
2	32331438	A98G	RT	gag-pol	HIV Infections	D G R S C L	View
3	32331438	D30N	PR	gag-pol	HIV Infections	D G R S C L	View
4	32331438	D67G	RT	gag-pol	HIV Infections	D G R S C L	View
5	32331438	D67N	RT	gag-pol	HIV Infections	D G R S C L	View
6	32331438	E138A	RT	gag-pol	HIV Infections	D G R S C L	View
7	32331438	E138G	RT	gag-pol	HIV Infections	D G R S C L	View
8	32331438	E138H	RT	gag-pol	HIV Infections	D G R S C L	View
9	32331438	E138K	RT	gag-pol	HIV Infections	D G R S C L	View
10	32331438	E138Q	RT	gag-pol	HIV Infections	D G R S C L	View
11	32331438	E138R	RT	gag-pol	HIV Infections	D G R S C L	View
12	32331438	E44D	RT	gag-pol	HIV Infections	D G R S C L	View
13	32331438	F227L	RT	gag-pol	HIV Infections	D G R S C L	View
14	32331438	G140A	IN	gag-pol	HIV Infections	D G R S C L	View
15	32331438	G190A	RT	gag-pol	HIV Infections	D G R S C L	View
16	32331438	G190S	RT	gag-pol	HIV Infections	D G R S C L	View
17	32331438	G48V	PR	gag-pol	HIV Infections	D G R S C L	View
18	32331438	H221Y	RT	gag-pol	HIV Infections	D G R S C L	View
19	32331438	I50L	PR	gag-pol	HIV Infections	D G R S C L	View
20	32331438	I50V	PR	gag-pol	HIV Infections	D G R S C L	View
21	32331438	I54A	PR	gag-pol	HIV Infections	D G R S C L	View
22	32331438	I54V	PR	gag-pol	HIV Infections	D G R S C L	View
23	32331438	K101E	RT	gag-pol	HIV Infections	D G R S C L	View
24	32331438	K101H	RT	gag-pol	HIV Infections	D G R S C L	View
25	32331438	K101P	RT	gag-pol	HIV Infections	D G R S C L	View
26	32331438	K101Q	RT	gag-pol	HIV Infections	D G R S C L	View
27	32331438	K103N	RT	gag-pol	HIV Infections	D G R S C L	View
28	32331438	K103S	RT	gag-pol	HIV Infections	D G R S C L	View
29	32331438	K219E	RT	gag-pol	HIV Infections	D G R S C L	View
30	32331438	K219N	RT	gag-pol	HIV Infections	D G R S C L	View
31	32331438	K219Q	RT	gag-pol	HIV Infections	D G R S C L	View
32	32331438	K238T	RT	gag-pol	HIV Infections	D G R S C L	View
33	32331438	K65D	RT	gag-pol	HIV Infections	D G R S C L	View
34	32331438	K65E	RT	gag-pol	HIV Infections	D G R S C L	View
35	32331438	K65N	RT	gag-pol	HIV Infections	D G R S C L	View
36	32331438	K70E	RT	gag-pol	HIV Infections	D G R S C L	View
37	32331438	K70R	RT	gag-pol	HIV Infections	D G R S C L	View
38	32331438	L100F	RT	gag-pol	HIV Infections	D G R S C L	View
39	32331438	L210W	RT	gag-pol	HIV Infections	D G R S C L	View
40	32331438	L74I	RT	gag-pol	HIV Infections	D G R S C L	View
41	32331438	L74V	RT	gag-pol	HIV Infections	D G R S C L	View
42	32331438	L76V	PR	gag-pol	HIV Infections	D G R S C L	View
43	32331438	L90M	PR	gag-pol	HIV Infections	D G R S C L	View
44	32331438	M184I	RT	gag-pol	HIV Infections	D G R S C L	View
45	32331438	M184V	RT	gag-pol	HIV Infections	D G R S C L	View
46	32331438	M230L	RT	gag-pol	HIV Infections	D G R S C L	View
47	32331438	M41L	RT	gag-pol	HIV Infections	D G R S C L	View
48	32331438	M46I	PR	gag-pol	HIV Infections	D G R S C L	View
49	32331438	M46L	PR	gag-pol	HIV Infections	D G R S C L	View
50	32331438	N155H	IN	gag-pol	HIV Infections	D G R S C L	View
51	32331438	N88S	PR	gag-pol	HIV Infections	D G R S C L	View
52	32331438	P225H	RT	gag-pol	HIV Infections	D G R S C L	View
53	32331438	Q148R	IN	gag-pol	HIV Infections	D G R S C L	View
54	32331438	T215C	RT	gag-pol	HIV Infections	D G R S C L	View
55	32331438	T215F	RT	gag-pol	HIV Infections	D G R S C L	View
56	32331438	T215I	RT	gag-pol	HIV Infections	D G R S C L	View
57	32331438	T215L	RT	gag-pol	HIV Infections	D G R S C L	View
58	32331438	T215N	RT	gag-pol	HIV Infections	D G R S C L	View
59	32331438	T215S	RT	gag-pol	HIV Infections	D G R S C L	View
60	32331438	T215Y	RT	gag-pol	HIV Infections	D G R S C L	View
61	32331438	T69D	RT	gag-pol	HIV Infections	D G R S C L	View
62	32331438	T69N	RT	gag-pol	HIV Infections	D G R S C L	View
63	32331438	V106A	RT	gag-pol	HIV Infections	D G R S C L	View
64	32331438	V108I	RT	gag-pol	HIV Infections	D G R S C L	View
65	32331438	V179D	RT	gag-pol	HIV Infections	D G R S C L	View
66	32331438	V179E	RT	gag-pol	HIV Infections	D G R S C L	View
67	32331438	V75A	RT	gag-pol	HIV Infections	D G R S C L	View
68	32331438	V75I	RT	gag-pol	HIV Infections	D G R S C L	View
69	32331438	V75M	RT	gag-pol	HIV Infections	D G R S C L	View
70	32331438	V82A	PR	gag-pol	HIV Infections	D G R S C L	View
71	32331438	V82F	PR	gag-pol	HIV Infections	D G R S C L	View
72	32331438	V82M	PR	gag-pol	HIV Infections	D G R S C L	View
73	32331438	V82S	PR	gag-pol	HIV Infections	D G R S C L	View
74	32331438	V82T	PR	gag-pol	HIV Infections	D G R S C L	View
75	32331438	Y115F	RT	gag-pol	HIV Infections	D G R S C L	View
76	32331438	Y181C	RT	gag-pol	HIV Infections	D G R S C L	View
77	32331438	Y181F	RT	gag-pol	HIV Infections	D G R S C L	View
78	32331438	Y181I	RT	gag-pol	HIV Infections	D G R S C L	View
79	32331438	Y181V	RT	gag-pol	HIV Infections	D G R S C L	View
80	32331438	Y188L	RT	gag-pol	HIV Infections	D G R S C L	View
81	32331438	Y188S	RT	gag-pol	HIV Infections	D G R S C L	View
82	32331438	Y318F	RT	gag-pol	HIV Infections	D G R S C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.